Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Clinical trial NCT06733675 · RECRUITING

Trial details

NCT number: NCT06733675
Sponsor: Basilea Pharmaceutica
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Pharmacokinetics Safety Drug-Drug Interaction (DDI)FDC

Start date: 2025-01-07
Primary completion: 2026-12-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.